ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A lipidomic study: Nobiletin ameliorates hepatic steatosis through regulation of lipid alternation

Yang, Xushan; Sun, Linye; Feng, Dongliang; Deng, Yudi; Liao, Wenzhen*南方医科大学
Journal of Nutritional Biochemistry2023-8DOI: 10.1016/j.jnutbio.2023.109353
3被引7阅读
引用收藏
分享

摘要

Hepatic lipidome has been given emphasis for years since hepatic steatosis is the most remarkable character of nonalcoholic fatty liver diseases, an increasingly serious health issue worldwide. Nobiletin (NOB), one of the citrus flavonoids, exerted outstanding effect on lipid metabolism disorder. However, the underlying mechanism of NOB exerting effect on hepatic lipid alternation remains unclear. In this study, the animal model was built by feeding APOE -/- mice with high fat diet (HFD). The results of Oil Red O-stained liver section and the biochemical assay of lipid parameters confirmed the protective effect of NOB on hepatic steatosis and global lipid metabolism disorder in APOE -/- mice. The hepatic lipidomic study revealed a total of 958 lipids significantly altered by HFD and a total of 86, 116, 212 lipid metabolites changed by L-NOB (50 mg/kg/d NOB), M-NOB (100 mg/kg/d NOB) and H-NOB (200 mg/kg/d NOB) respectively. In the further screening analysis, an amount of 60 lipids were identified as the potential lipid markers of NOB treatment, most of which belonged to glycerophospholipids lipid categories and exhibited obvious correlation with each other and the lipid parameters related to hepatic steatosis. Taken together, our data demonstrated that glycerophospholipids metabolism played an indispensable role in the progression of hepatic steatosis and the protective effect of NOB. Besides, the modulation towards genes involved in lipid synthesis was observed after NOB administration in this study. These finding illustrated the antihepatic steatosis effect of NOB based on altering hepatic lipidome, particularly the glycerophospholipids metabolism, and provided a new insight in the pathogenesis of hepatic steatosis.

学科与关键词

关键词
NOBhepatic steatosishepatic lipidomic studyglycerophospholipids metabolismAPOE--
相关
加载中…
  • Nobiletin mitigates NAFLD via lipophagy and inflammation
    Yang, Xushan; Deng, Yudi; Tu, Yali; Feng, Dongliang; Liao, Wenzhen*Food & Function, 2022, 13(19): 10186-10199.被引 6
  • Beneficial effects of nobiletin on regulation of lipid metabolism
    Hao, Yuting; Xiang, Qianru; Ye, Zichong; Feng, Dongliang; Ye, Huarui; He, Shengping*; Liao, Wenzhen*Food Bioscience, 2024, 57: 103484.
  • Liver-Specific Bmal1 Depletion Reverses the Beneficial Effects of Nobiletin on Liver Cholesterol Homeostasis in Mice Fed with High-Fat Diet
    Lu, Zhitian; Li, Xudong; Wang, Min; Zhang, Xiaojun; Zhuang, Runxuan; Wu, Fan; Li, Wenxue; Zhu, Wei*; Zhang, Bo*OncoImmunology, 2023, 15(11): 2547.
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Nutritional Biochemistry
发表日期
2023-08
卷期
第 118 卷
页码
109353
DOI
10.1016/j.jnutbio.2023.109353
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81973013]; Guangdong Basic and Applied Basic Research Foundation [2023A1515011065]

作者

  • Y

    Yang, Xushan (第一作者)

    southern med univ

  • S

    Sun, Linye

    southern med univ

查看全部 5 位作者收起作者
  • F

    Feng, Dongliang

    southern med univ

  • D

    Deng, Yudi

    southern med univ

  • L

    Liao, Wenzhen (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417